LobSor Pharmaceuticals Aktiebolag
556930-4768ActiveDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
Pharmaceutical Companylobsor.com
Yleiskatsaus
- 1–4
- Työntekijät
- 100–500milj SEK
- Liikevaihto
- 2013
- Perustettu
Kuvaus
Lobsor Pharmaceuticals AB is a Swedish company dedicated to developing innovative therapeutic systems for complex medical conditions. Their primary focus is on creating advanced treatments specifically targeting advanced Parkinson’s disease. The company's flagship product is Lecigon, a novel therape...
Tunnisteet
B2BPharmaceuticalsTechnology
Avainsanat
Biotechnology